Clinical Trials Browser

Has results × Liver Neoplasms × regorafenib × Clear all

NCT04696055 2025-05-13

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

Phase 2 Completed

95 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms